Other Pharmaceuticals and Biotechnology · San Francisco, CA · Founded 2019 · Privately Held (backing)
Developer of a drug discovery tool designed to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS). Nalu Bio is based in San Francisco, CA and was founded in 2019. It has raised $13.5 million across 2 recorded rounds; the latest was an accelerator round in Mar 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$13.5M
Last round
Accelerator/Incubator
Mar 2025
No prints on record
No secondary trades in Nalu Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nalu Bio with a free account
·Watch Nalu Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Nalu Bio stock.
